Satoshi Yoshiji

1.4k total citations · 1 hit paper
34 papers, 604 citations indexed

About

Satoshi Yoshiji is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Satoshi Yoshiji has authored 34 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Satoshi Yoshiji's work include Genetic Associations and Epidemiology (10 papers), Diabetes Treatment and Management (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Satoshi Yoshiji is often cited by papers focused on Genetic Associations and Epidemiology (10 papers), Diabetes Treatment and Management (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Satoshi Yoshiji collaborates with scholars based in Japan, Canada and United Kingdom. Satoshi Yoshiji's co-authors include J. Brent Richards, Tianyuan Lu, Guillaume Butler‐Laporte, Tomoko Nakanishi, Celia M.T. Greenwood, Vincenzo Forgetta, Yiheng Chen, Yossi Farjoun, Kevin Y. H. Liang and Chen‐Yang Su and has published in prestigious journals such as Nature Communications, Nature Genetics and Bioinformatics.

In The Last Decade

Satoshi Yoshiji

30 papers receiving 602 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases

2023 421 citations Yiheng Chen, Tianyuan Lu et al. Nature Genetics profile →

Peers

Countries citing papers authored by Satoshi Yoshiji

Since Specialization

Citations

This map shows the geographic impact of Satoshi Yoshiji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Yoshiji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Yoshiji more than expected).

Fields of papers citing papers by Satoshi Yoshiji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Yoshiji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Yoshiji. The network helps show where Satoshi Yoshiji may publish in the future.

Co-authorship network of co-authors of Satoshi Yoshiji

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Yoshiji. A scholar is included among the top collaborators of Satoshi Yoshiji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Yoshiji. Satoshi Yoshiji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities 2025 ·Nature Communications ·Ana Luiza Arruda, Ozvan Bocher, Henry J. Taylor, Davis Cammann, Satoshi Yoshiji, Xianyong Yin, Chi Zhao, Jingchun Chen, Alexis C. Wood, Ken Suzuki, Josep M. Mercader, Cassandra N. Spracklen, James B. Meigs, Marijana Vujković, George Davey Smith, Jerome I. Rotter, Benjamin F. Voight, Andrew P. Morris, Eleftheria Zeggini	0
2	Leveraging Proteomics and Proteogenomics for Understanding Osteoporosis and Other Musculoskeletal Diseases 2025 ·Current Osteoporosis Reports ·(unknown), Chen‐Yang Su, Douglas P. Kiel, Satoshi Yoshiji	0
3	Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials 2025 ·Diabetes Obesity and Metabolism ·(unknown), Chen‐Yang Su, (unknown), (unknown), Daisuke Yabe, Nobuya Inagaki, Satoshi Yoshiji	0
4	MR Corge: sensitivity analysis of Mendelian randomization based on the core gene hypothesis for polygenic exposures 2024 ·Bioinformatics ·Wenmin Zhang, Chen‐Yang Su, Satoshi Yoshiji, Tianyuan Lu	1
5	Metabolomic pattern associated with physical sequelae in patients presenting with respiratory symptoms validates the aestivation concept in dehydrated patients 2024 ·Physiological Genomics ·(unknown), Guillaume Butler‐Laporte, Satoshi Yoshiji, David Morrison, Tomoko Nakanishi, Yiheng Chen, Vincenzo Forgetta, Yossi Farjoun, Adriana Marton, Jens Titze, (unknown), Robert Frithiof, Miklós Lipcsey, J. Brent Richards, Michael Hultström	2
6	The Influence of Trinucleotide Repeats in the Androgen Receptor Gene on Androgen-related Traits and Diseases 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Takayoshi Sasako, (unknown), Kevin Y. H. Liang, Yiheng Chen, Satoshi Yoshiji, J. Brent Richards	3
7	Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia 2024 ·Circulation Genomic and Precision Medicine ·Maddalena Ardissino, Buu Truong, Eric A. W. Slob, Art Schuermans, Satoshi Yoshiji, Alec Morley, Stephen Burgess, Fu Siong Ng, Antonio de Marvao, Pradeep Natarajan, K. H. Nicolaides, Liam Gaziano, Adam S. Butterworth, Michael C. Honigberg	2
8	Circulating Metabolite Abundances Associated With Risks of Bipolar Disorder, Schizophrenia, and Depression: A Mendelian Randomization Study 2024 ·Biological Psychiatry ·Tianyuan Lu, Yiheng Chen, Satoshi Yoshiji, Yann Ilboudo, Vincenzo Forgetta, Sirui Zhou, Celia M.T. Greenwood	7
9	Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs 2023 ·Human Genetics ·Julian Willett, Tianyuan Lu, Tomoko Nakanishi, Satoshi Yoshiji, Guillaume Butler‐Laporte, Sirui Zhou, Yossi Farjoun, J. Brent Richards	1
10	Predicting ExWAS findings from GWAS data: a shorter path to causal genes 2023 ·Human Genetics ·Kevin Y. H. Liang, Yossi Farjoun, Vincenzo Forgetta, Yiheng Chen, Satoshi Yoshiji, Tianyuan Lu, J. Brent Richards	4
11	A phenome-wide association study (PheWAS) to identify the health impacts of 4-cresol sulfate in the Nagahama Study 2023 ·Scientific Reports ·(unknown), Shuji Kawaguchi, Kazuhiro Sonomura, Takahisa Kawaguchi, (unknown), Satoshi Yoshiji, François Brial, Dominique Gauguier, Jianguo Xia, Fumihiko Matsuda	2
12	Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials 2023 ·Cardiovascular Diabetology ·(unknown), Satoshi Yoshiji, (unknown), (unknown), Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki, Nobuya Inagaki	13
13	Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach 2023 ·International Journal of Epidemiology ·Guillaume Butler‐Laporte, Yossi Farjoun, Yiheng Chen, Michael Hultström, Kevin Y. H. Liang, Tomoko Nakanishi, Chen‐Yang Su, Satoshi Yoshiji, Vincenzo Forgetta, J. Brent Richards	13
14	Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases breakdown → 2023 ·Nature Genetics ·Yiheng Chen, Tianyuan Lu, U. Pettersson, Isobel D. Stewart, Guillaume Butler‐Laporte, Tomoko Nakanishi, Agustin Cerani, Kevin Y. H. Liang, Satoshi Yoshiji, Julian Willett, Chen‐Yang Su, Parminder Raina, Celia M.T. Greenwood, Yossi Farjoun, Vincenzo Forgetta, Claudia Langenberg, Sirui Zhou, Claes Ohlsson, J. Brent Richards	421
15	Stabilization of kidney function and reduction in heart failure events with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis and meta‐regression analysis 2023 ·Diabetes Obesity and Metabolism ·(unknown), Satoshi Yoshiji, (unknown), (unknown), Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Nobuya Inagaki	2
16	Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study 2022 ·Diabetes Therapy ·Satoshi Yoshiji, (unknown), (unknown), Kimitaka Shibue, (unknown), (unknown), Kanako Iwasaki, Sachiko Honjo, (unknown), Akihiro Hamasaki	2
17	Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study 2022 ·Critical Care ·Michael Hultström, Miklós Lipcsey, David Morrison, Tomoko Nakanishi, Guillaume Butler‐Laporte, Yiheng Chen, Satoshi Yoshiji, Vincenzo Forgetta, Yossi Farjoun, Ewa Wallin, Ing‐Marie Larsson, Anders Larsson, Adriana Marton, Jens Titze, (unknown), J. Brent Richards, Robert Frithiof	7
18	Identification of the first Japanese family with PDX1-MODY (MODY4): a novel PDX1 frameshift mutation, clinical characteristics, and implications 2021 ·Zenodo (CERN European Organization for Nuclear Research) ·Satoshi Yoshiji, Yukio Horikawa, (unknown), Mayumi Enya, (unknown), (unknown), Megumi Aizawa‐Abe, Kanako Iwasaki, Sachiko Honjo, Kazuyoshi Hosomichi, Daisuke Yabe, Akihiro Hamasaki	1
19	First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications 2021 ·Journal of the Endocrine Society ·Satoshi Yoshiji, Yukio Horikawa, (unknown), Mayumi Enya, (unknown), (unknown), Megumi Aizawa‐Abe, Kanako Iwasaki, Sachiko Honjo, Kazuyoshi Hosomichi, Daisuke Yabe, Akihiro Hamasaki	16
20	Chronic primary adrenal insufficiency after unilateral adrenonephrectomy 2017 ·Medicine ·Satoshi Yoshiji, Kimitaka Shibue, Toshihito Fujii, Takeshi Usui, Keisho Hirota, Daisuke Taura, Mayumi Inoue, Masakatsu Sone, Akihiro Yasoda, Nobuya Inagaki	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact